As we get deeper into flu season, a new type of the influenza virus has been identified, the Centers for Disease Control and ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...
A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated ...
Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...
In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.
IFLScience on MSN
Is mRNA The Future Of Flu Shots? New Vaccine 34.5 Percent More Effective Than Standard Shots In Trials
A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...
Flu season tends to peak from December to February. What to know about getting a flu shot or COVID-19 vaccine.
The American College of Physicians (ACP) issued new influenza vaccine practice points that say everyone ages 18 to 64 years who are not pregnant or immunocompromised should receive either a ...
Influenza remains a significant global health burden, causing millions of visits and tens of thousands of deaths in the U.S. annually. The virus evolves constantly through antigenic drift and shift, ...
The American College of Physicians (ACP) issued new practice points stating that adults over age 65 should receive either a standard-dose trivalent or a standard-dose quadrivalent influenza vaccine ...
News-Medical.Net on MSN
Apriori Bio and A*STAR collaborate to develop next generation saRNA influenza vaccines
Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results